
201 - 500 employees
Founded 2013
đ„ Healthcare
đ Manufacturing
đ§Ź Biotechnology
Healthcare âą Manufacturing âą Biotechnology
Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to prevent and treat serious bacterial infections. The company develops broad-spectrum conjugate and novel protein vaccinesâusing modern synthetic chemistry and a proprietary cell-free protein synthesis platform licensed from Sutro Biopharmaâto create difficult-to-make protein antigens more efficiently. Its lead programs are pneumococcal conjugate vaccine candidates VAX-31 (31-valent) and VAX-24 (24-valent) in Phase 2/3 studies, with earlier-stage candidates targeting Group A Strep and Shigella; Vaxcyte focuses on reducing invasive bacterial disease burden, antibiotic resistance consequences, and related morbidity in vulnerable populations.
đ June 4
đ California â Remote
đ” $170k - $198k / year
â° Full Time
đ Senior
đ Director
đŠ H1B Visa Sponsor
đ» Ghost score 7%
Improve your chances of getting an interview by checking your resume score before you apply.

201 - 500 employees
Founded 2013
đ„ Healthcare
đ Manufacturing
đ§Ź Biotechnology
Healthcare âą Manufacturing âą Biotechnology
Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to prevent and treat serious bacterial infections. The company develops broad-spectrum conjugate and novel protein vaccinesâusing modern synthetic chemistry and a proprietary cell-free protein synthesis platform licensed from Sutro Biopharmaâto create difficult-to-make protein antigens more efficiently. Its lead programs are pneumococcal conjugate vaccine candidates VAX-31 (31-valent) and VAX-24 (24-valent) in Phase 2/3 studies, with earlier-stage candidates targeting Group A Strep and Shigella; Vaxcyte focuses on reducing invasive bacterial disease burden, antibiotic resistance consequences, and related morbidity in vulnerable populations.
âą Serve as the CMC statistical lead for the VSWG, supporting specification-setting strategy for drug substance, drug product, intermediates, raw materials, release testing, stability testing, and in-process testing. âą Develop statistical strategies for specification and JOS using clinical experience, manufacturing experience, stability behavior, analytical variability, assay capability, and process capability. âą Design and execute statistical analyses such as confidence intervals, prediction intervals, tolerance intervals, regression, ANOVA, DOE, equivalence testing, trend analysis, control charts, and Cpk/process capability analyses. âą Provide statistical input to late-stage development, PPQ, BLA/MAA preparation, health authority responses, commercial readiness, and specification lifecycle management. âą Author and review statistical sections of specification and JOS documents, CMC technical reports, regulatory submission sections, and briefing materials. âą Assess analytical method performance and method lifecycle changes, including precision, transfer/bridging, comparability, and impact of analytical variability on specification decisions. âą Partner with Process Development, MSAT, Stability, QA, RA, Manufacturing, and external partners to align statistical rationale with CMC control strategy and regulatory expectations. âą Support PPQ, APR, and CPV activities by evaluating process consistency, state of control, trends, internal control limits, and capability relative to proposed or registered specifications. âą Translate complex statistical concepts into clear recommendations for cross-functional teams, senior leaders, and non-statistical stakeholders; support audits, inspections, and health authority interactions as needed.
âą MS or PhD in Statistics, Biostatistics, Applied Statistics, Mathematics, Data Science, or a related quantitative discipline with 10+ years of experience in the pharmaceutical or biotechnology industry. âą Significant hands-on experience in CMC statistics, including specification setting, JOS preparation, analytical method evaluation, stability analysis, process validation, PPQ, CPV, and/or commercial manufacturing support. âą Demonstrated experience supporting BLA, MAA, IND, or major health authority submissions and responses; BLA experience strongly preferred. âą Strong understanding of late-stage and commercial specification-setting principles, including clinical relevance, patient-centric justification, manufacturing experience, analytical capability, stability data, and lifecycle considerations. âą Experience with vaccines, biologics, complex modalities, multivalent products, conjugates, or adjuvanted products is strongly preferred. âą Strong expertise in statistical methods used in CMC and analytical development, including regression, ANOVA, DOE, equivalence testing, tolerance/prediction intervals, control charts, process capability, and stability/shelf-life modeling. âą Proficiency with statistical software such as R, SAS, JMP, Python, Minitab, or equivalent tools. âą Comprehensive understanding of relevant regulatory expectations and guidance, including FDA, EU, WHO, and ICH principles applicable to biologics/vaccines, specifications, analytical methods, validation, stability, and lifecycle management. âą Significant experience authoring technical and regulatory-ready documents, including statistical reports, JOS sections, protocols, validation reports, SOPs, and CMC submission content. âą Excellent communication and interpersonal skills, both written and verbal; able to explain complex statistical concepts clearly and influence cross-functional decisions in a fast-paced environment. âą Strong strategic and analytical decision-making skills; able to navigate ambiguity, prioritize across competing demands, and implement practical, phase-appropriate, and compliant approaches. âą Self-starter with proven project management capability and the ability to work independently in a remote, matrixed, and highly collaborative environment.
âą Comprehensive benefits package âą Equity component
Apply Nowđ June 2
Analytics leader driving advanced data science initiatives within commercial pharma at Tiger Analytics. Focusing on building NBA frameworks and omnichannel engagement strategies for personalized journeys.
đ May 31
Senior Director Strategic Insights driving enterprise strategy execution by integrating consumer research and performance management at Geisinger. Leading insights to inform decisions and accountability across the organization.
đ May 28
Senior Director of Data Strategy overseeing Wpromote's data strategy team and enterprise client analytics. Leading cross-functional teams to deliver data-driven solutions and measurement strategies.
đ May 28
Sales Director leading Strategic Enterprise Account Executives for Databricks, the Data and AI company. Driving retail customer growth, quota attainment, consumption, and partner success.
đșđž United States â Remote
đ” $440k - $605k / year
đ° $1.6G Series H on 2021-08
â° Full Time
đ Senior
đ Director
đŠ H1B Visa Sponsor
đ May 28
Senior Director implementing AI-powered instructional tools across partner school systems. Leading implementation systems, product feedback, and instructional improvement for priority student groups.